Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,521 | 813 | 851 | 961 | 1,147 |
| Income taxes - deferred | 0 | -3,856 | N/A | N/A | N/A |
| Accounts receivable | 9 | 66 | 103 | -167 | 404 |
| Accounts payable and accrued liabilities | -1,505 | 1,136 | 2,516 | N/A | N/A |
| Other Working Capital | -2,230 | 951 | 2,743 | -318 | -922 |
| Other Operating Activity | -14,699 | -3,634 | -12,760 | -1,831 | -4,967 |
| Operating Cash Flow | $-16,904 | $-4,523 | $-6,547 | $-1,356 | $-4,338 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54 | 65 | 3 | -16 | -11 |
| Net Acquisitions | 0 | 4 | N/A | N/A | N/A |
| Purchase Of Investment | -9,998 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | 0 | -1,135 | -71 |
| Other Investing Activity | -32 | -104 | -34 | 0 | 1,567 |
| Investing Cash Flow | $-10,084 | $-36 | $-31 | $-1,151 | $1,485 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 376 | N/A | 0 | 4,693 |
| Debt Repayment | -1,600 | -34 | -45 | -12 | 0 |
| Common Stock Issued | 48,307 | 5,861 | 762 | 2,294 | 29 |
| Other Financing Activity | 1,183 | 2 | 0 | 0 | -79 |
| Financing Cash Flow | $47,890 | $6,205 | $717 | $2,282 | $4,643 |
| Exchange Rate Effect | -17 | 0 | -33 | -71 | -240 |
| Beginning Cash Position | 1,821 | 173 | 6,079 | 6,218 | 4,798 |
| End Cash Position | 22,706 | 1,819 | 185 | 5,924 | 6,348 |
| Net Cash Flow | $20,902 | $1,646 | $-5,861 | $-224 | $1,790 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,904 | -4,523 | -6,547 | -1,356 | -4,338 |
| Capital Expenditure | -90 | -104 | -39 | -1,151 | -85 |
| Free Cash Flow | -16,994 | -4,627 | -6,586 | -2,506 | -4,423 |